Endurant Capital Management LP purchased a new stake in shares of BioAtla, Inc. (NASDAQ:BCAB – Get Rating) in the 4th quarter, according to the company in its most recent Form 13F filing with the Securities & Exchange Commission. The fund purchased 136,382 shares of the company’s stock, valued at approximately $1,125,000. Other hedge funds have […]